Drug intelligence / Profile preview

Abiewhite

Development stage: Unknown
Lead developer: Phytodia
Administration: Topical

Overview

Abiewhite is a cosmetic active ingredient developed by Laboratoires Phytodia, a French company specializing in plant-based ingredients. Derived from *Abies alba* (silver fir) extract and formulated in a base of glycerin and water, it is designed for topical application to address skin hyperpigmentation and dark spots. The ingredient is marketed for its depigmenting and antioxidant properties, specifically targeting age spots and neutralizing free radicals to provide anti-aging benefits. Sourced from the Vosges region, it is positioned as a natural, locally-sourced solution for cosmetic formulations aimed at skin brightening and evening skin tone.

Brand names: Abiewhite
Other names: Abies alba extract

Targets

TYR (Tyrosinase)

Beyond the preview

Go deeper on Abiewhite.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Abiewhite.

Explore the full profile